Genotoxic classification of anticancer drugs.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Teratogenesis, carcinogenesis, and mutagenesis (Print)

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/TCM.1770050502PMID 2867614
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effects of excision repair and the plasmid pKM101 on the induction of his+ revertants by chemical agents in Salmonella typhimurium.

  1983cited by this paper
• Mutagenic responses of thirteen anticancer drugs on mutation induction at multiple genetic loci and on sister chromatid exchanges in Chinese hamster ovary cells.

  1983cited by this paper
• WHO-IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Vol. 26. Some Antineoplastic and Immunosuppressive Agents. 411 Seiten. International Agency for Research on Cancer, Lyon 1981. Preis: 62.- sfrs; 30.- US $

  1982cited by this paper
• Risk of handling injectable antineoplastic agents.

  1982cited by this paper
• Exposure of pharmacy personnel to mutagenic antineoplastic drugs.

  1982cited by this paper
• A new Salmonella tester strain (TA102) with A X T base pairs at the site of mutation detects oxidative mutagens.

  1982cited by this paper
• Phase I trial of PCNU administered by 5-day courses.

  1981cited by this paper
• The mutagenic effect of cis-diamminedichloroplatinum (II) and its degradation products in the Ames microbial assay.

  1981cited by this paper
• Mutagenic activity of nitrosourea antitumor agents.

  1980cited by this paper
• Bacterial mutagenesis: review of new insights.

  1980cited by this paper
• Carcinogenicity of antitumor cis-platinum(II) coordination complexes in the mouse and rat.

  1979cited by this paper
• Comparison of the relative mutagenic activity for eight antineoplastic drugs in the Ames Salmonella/microsome and TK+/- mouse lymphoma assays.

  1978cited by this paper
• Mutagenicity of cancer chemotherapeutic agents in the Salmonella/microsome test.

  1977cited by this paper
• Bioassay program for carcinogenic hazards of cancer chemotherapeutic agents

  1977cited by this paper
• Tumorigenicity in vivo and induction of malignant transformation and mutagenesis in cell cultures by adriamycin and daunomycin.

  1976cited by this paper
• Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test.

  1975cited by this paper
• Experimental investigations with anti-cancer drugs for carcinogenicity with special reference to immunedepression.

  1975cited by this paper
• Detection of carcinogens as mutagens: bacterial tester strains with R factor plasmids.

  1975cited by this paper
• Correlation between deoxyribonucleic acid excision-repair and life-span in a number of mammalian species.

  1974cited by this paper
• Test for carcinogenicity of food additives and chemotherapeutic agents by the pulmonary tumor response in strain A mice.

  1973cited by this paper
• Renal tumors and other lesions in rats following a single intravenous injection of daunomycin.

  1972cited by this paper
• SUBCUTANEOUS SARCOMAS INDUCED BY MITOMYCIN C IN MICE: Comparisons of Occurrence, Transplantability and Histology Between Sarcomas Induced by Actinomycin S and 3‐Methylcholanthrene *

  1967cited by this paper

• The interplay between anticancer challenges and the microbial communities from the gut

  2022cites this paper
• Utility of a next‐generation framework for assessment of genomic damage: A case study using the pharmaceutical drug candidate etoposide

  2021cites this paper
• Genotoxic Monitoring of Nurses Handling Cytotoxic Drugs

  2016cites this paper
• Evaluation of in vivo gene mutation with etoposide using Pig-a and PIGRET assays.

  2016cites this paper
• A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.

  2011cites this paper
• Estimation of the cancer risk to humans resulting from the presence of cyclophosphamide and ifosfamide in surface water

  2010cites this paper
• Entwicklung und Anwendung von LC-MS/MS Multimethoden zur Bestimmung von Antibiotika und Zytostatika bei Arbeitsschutz- und Umweltuntersuchungen

  2007cites this paper
• Sister Chromatid Exchange Induction in Patients with Anaplastic Gliomas Undergoing Treatment with Radiation plus Diaziquone or l , 3-Bis ( 2-chloroethyl )-l-nitrosourea

  2006cites this paper
• Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques.

  2006cites this paper
• Cytogenetic risk assessment of etoposide from mouse bone marrow

  2004influential citation
• FOLLOW-UP GENOTOXICOLOGICAL MONITORING OF NURSES HANDLING ANTINEOPLASTIC DRUGS

  2001cites this paper
• Correlation between cell survival and micronuclei formation in V79 cells treated with vindesine before exposure to different doses of gamma-radiation.

  2000cites this paper
• Determination of the vaporization of solutions of mutagenic antineoplastic agents at 23 and 37 degrees C using a desiccator technique.

  2000cites this paper
• Determination of the vaporization of solutions of mutagenic antineoplastic agents at 23 and 37°C using a desiccator technique

  2000cites this paper
• Effect of teniposide (VM-26) on the cell survival, micronuclei-induction and lactate dehydrogenase activity on V79 cells.

  1999cites this paper
• Permeability of nitrile rubber, latex, polyurethane, and neoprene gloves to 18 antineoplastic drugs.

  1999cites this paper
• Sicherer Umgang mit Zytostatika

  1999cites this paper
• Pharmaceuticals in the environment--a human risk?

  1998cites this paper
• Nurses' and pharmacists' exposure to antineoplastic drugs: findings from industrial hygiene scans and urine mutagenicity tests.

  1998cites this paper
• Chemicals mutagenic in Salmonella typhimurium strain TA1535 but not in TA100.

  1998cites this paper
• Birth defects and childhood cancer in offspring of survivors of childhood cancer.

  1997cites this paper
• Cytogenetic analysis in peripheral lymphocytes of cancer patients treated with cytostatic drugs: results from an EC Collaborative Study.

  1996cites this paper
• Monitoring occupational exposure to cancer chemotherapy drugs.

  1996cites this paper
• Trace analysis of the antineoplastics ifosfamide and cyclophosphamide in sewage water by twostep solid-phase extraction and gas chromatography-mass spectrometry

  1996cites this paper
• Permeability testing of glove materials for use with cancer chemotherapy drugs.

  1995cites this paper
• Genotoxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).

  1995cites this paper
• Etoposide (VP‐16): Cytogenetic studies in mice

  1994cites this paper
• Topoisomerase II enzymes and mutagenicity

  1994cites this paper
• International Commission for Protection Against Environmental Mutagens and Carcinogens. Mutagenicity and carcinogenicity of topoisomerase-interactive agents.

  1994cites this paper
• Mutagenicity and carcinogenicity of topoisomerase-interactive agents

  1994cites this paper
• Biological Factors Related to Male Mediated Reproductive and Developmental Toxicity

  1994cites this paper
• potent clastogenicity of the human carcinogen etoposide to the mouse bone marrow and mouse lymphoma L5178Y cells: Comparison to salmonella responses

  1994cites this paper
• The genetic toxicology of 6-mercaptopurine.

  1993cites this paper
• An Evaluation of the Permeability of Disposable Polypropylene-Based Protective Gowns to a Battery of Cancer Chemotherapy Drugs

  1993cites this paper
• Prophage induction by DNA topoisomerase II poisons and reactive-oxygen species: role of DNA breaks.

  1992cites this paper
• A Report on the National Commission on Cytotoxic Exposure

  1992cites this paper
• The genotoxicity of the anti-cancer drug mitoxantrone in somatic and germ cells of Drosophila melanogaster.

  1992cites this paper
• Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence.

  1991cites this paper
• Biological safety cabinetry

  1991cites this paper
• Modifying effects of anticancer drugs adriamycin, actinomycin D, and cisplatin on N-2-fluorenylacetamide-induced hepatocarcinogenesis in male ACI/N rats.

  1991cites this paper
• DNA adducts of the antitumor agent diaziquone.

  1991cites this paper
• Uterine and Embryonic Factors in Early Pregnancy

  1991cites this paper
• Biological monitoring screening of patients provided antineoplastic drugs including adriamycin, cyclophosphamide, 5-fluorouracil, methotrexate, and vincristine.

  1990cites this paper
• Comparison of three assays for genetic effects of antineoplastic drugs on cancer patients and their nurses

  1990cites this paper
• Tests for the genotoxicity of m-AMSA, etoposide, teniposide and ellipticine in Neurospora crassa.

  1990cites this paper
• Quantitative evaluation of the effects of human carcinogens and related chemicals on human foreskin fibroblasts

  1990cites this paper
• Effects of in vivo exposure to antineoplastic drugs on DNA repair and replication in human lymphocytes.

  1990cites this paper
• Mutagenesis assays on urines produced by patients administered adriamycin and cyclophosphamide

  1990cites this paper
• Influence of the Uvr repair system on the mutagenicity of antiparasitic drugs.

  1989cites this paper
• Mutagenicity of topoisomerase-active agents in bacteriophage T4.

  1988cites this paper
• Sister-chromatid exchanges in human lymphocytes exposed to 1-p-(3-methyltriazeno)benzoic acid potassium salt.

  1988cites this paper
• The mutagenicity of urine fractions from patients administered antineoplastic therapy.

  1988cites this paper
• Etoposide (VP16) and teniposide (VM26): novel anticancer drugs, strongly mutagenic in mammalian but not prokaryotic test systems.

  1987cites this paper
• Sister chromatid exchange induction in patients with anaplastic gliomas undergoing treatment with radiation plus diaziquone or 1,3-bis(2-chloroethyl)-1-nitrosourea.

  1987cites this paper
• Cytogenetic effects of 1-p-(3-methyltriazeno)benzoic acid potassium salt on human lymphocytes in vitro.

  1987cites this paper
• Diaziquone-induced micronuclei in cytochalasin B-blocked mouse peripheral blood lymphocytes.

  1987cites this paper
• Genotoxic effects of cisplatin in somatic tissue of Drosophila melanogaster

  1987cites this paper
• Stability and inactivation of mutagenic drugs and their metabolites in the urine of patients administered antineoplastic therapy

  1987cites this paper
• Diaziquione-induced micronuclei in cytochalasin B-blocked mouse peripheral blood lymphocytes ☆

  1987cites this paper
• Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK +/- -3.7.2C mouse lymphoma cells.

  1987cites this paper
• Target sequences for mutagenesis in Salmonella histidine-requiring mutants.

  1986cites this paper
• Re-evaluation of urine mutagenicity of pharmacy personnel exposed to antineoplastic agents.

  1986cites this paper
• Mutagenesis by Patients and Assays on Urines Produced Administered Ad ria myc i n Cyclophosphamide

  year unknowncites this paper